Treatment

• Adult Acute Myeloid Leukemia Treatment (PDQ®)
  [ patient ] ¹ [ health professional ] ²
  Expert-reviewed information summary about the treatment of adult acute myeloid leukemia.
• Childhood Acute Myeloid Leukemia/Other Myeloid Malignancies Treatment (PDQ®)
  [ patient ] ³ [ health professional ] ⁴
  Expert-reviewed information summary about the treatment of childhood acute myeloid leukemia, myelodysplastic syndromes, and other myeloproliferative disorders.
• Chronic Myelogenous Leukemia Treatment (PDQ®)
  [ patient ] ⁵ [ health professional ] ⁶
  Expert-reviewed information summary about the treatment of chronic myelogenous leukemia.
• Chronic Myeloproliferative Disorders Treatment (PDQ®)
  [ patient ] ⁷ [ health professional ] ⁸
  Expert-reviewed information summary about the treatment of chronic myeloproliferative disorders.
• Myelodysplastic Syndromes Treatment (PDQ®)
  [ patient ] ⁹ [ health professional ] ¹⁰
  Expert-reviewed information summary about the treatment of myelodysplastic syndromes.
• Myelodysplastic/ Myeloproliferative Neoplasms Treatment (PDQ®)
  [ patient ] ¹¹ [ health professional ] ¹²
  Expert-reviewed information summary about the treatment of myelodysplastic/myeloproliferative neoplasms including chronic/juvenile myelomonocytic leukemias and atypical CML.
• Drugs Approved for Myeloproliferative Disorders ¹³
  This page lists cancer drugs approved by the Food and Drug Administration (FDA) for myeloproliferative disorders. The list includes generic names, brand names, and common drug combinations, which are shown in capital letters. The drug names link to NCI's Cancer Drug Information summaries.
• Biological Therapies for Cancer ¹⁴
  A fact sheet that provides an overview of how the immune system functions and describes the actions of biological therapies.
• Biological Therapy ¹⁵
  An introduction to biological therapy to help patients prepare to receive it for cancer treatment or managing side effects.
• Imatinib mesylate (Gleevec®) ¹⁶
  A collection of material on imatinib mesylate (Gleevec®), the first approved drug to directly turn off the signal of a protein known to cause a cancer.
• Bone Marrow Transplantation and Peripheral Blood Stem Cell Transplantation ¹⁷
  A fact sheet that explains the step-by-step procedures of two types of transplantations used with high-dose chemotherapy, including their risks and benefits.
• Care for Children and Adolescents with Cancer ¹⁸
  A fact sheet about children's cancer centers and health care approaches, including clinical trials for children with cancer.